Mucormycosis - Case series on uninvited resident evil in COVID-19 patients
Kandra, N., Uppala, P., Vangoori, Y., U, U., Shabana, S., S V, S., Butti, L. (2023). Mucormycosis - Case series on uninvited resident evil in COVID-19 patients. EKB Journal Management System, 24(24), 1-6. doi: 10.21608/ejentas.2022.137166.1513
Nagavishnu Kandra; Praveen Kumar Uppala; Yakaiah Vangoori; Upendrarao U; SK M Shabana; Saibaba S V; Lavanya Butti. "Mucormycosis - Case series on uninvited resident evil in COVID-19 patients". EKB Journal Management System, 24, 24, 2023, 1-6. doi: 10.21608/ejentas.2022.137166.1513
Kandra, N., Uppala, P., Vangoori, Y., U, U., Shabana, S., S V, S., Butti, L. (2023). 'Mucormycosis - Case series on uninvited resident evil in COVID-19 patients', EKB Journal Management System, 24(24), pp. 1-6. doi: 10.21608/ejentas.2022.137166.1513
Kandra, N., Uppala, P., Vangoori, Y., U, U., Shabana, S., S V, S., Butti, L. Mucormycosis - Case series on uninvited resident evil in COVID-19 patients. EKB Journal Management System, 2023; 24(24): 1-6. doi: 10.21608/ejentas.2022.137166.1513

Mucormycosis - Case series on uninvited resident evil in COVID-19 patients

Egyptian Journal of Ear, Nose, Throat and Allied Sciences
Article 46, Volume 24, Issue 24, January 2023, Page 1-6  XML PDF (575.09 K)
Document Type: Case report
DOI: 10.21608/ejentas.2022.137166.1513
View on SCiNiTO View on SCiNiTO
Authors
Nagavishnu Kandra1; Praveen Kumar Uppala email orcid 2; Yakaiah Vangoori3; Upendrarao U4; SK M Shabana5; Saibaba S V5; Lavanya Butti6
1Dr.NTR university of Health sciences
2Employment ID- IPC-291, NCC-PvPI, Indian Pharmacoepia Commission
3Dr.NTR University of Health Sciences
4JNTUK
5JNTUH
6Dr.N T R University of Health sciences
Abstract
Mucormycosis is an aggressive opportunistic infection ascribed to the inhalation of fungal spores which, normally infect the nose and paranasal sinuses. This fulminant form commonly infects immunosuppressed human hosts, especially patients with AIDS, poorly controlled diabetes, lymphoma, leukemia, and those on long-term steroid use. The rise in patients with rhino-orbital mucormycosis associated with COVID-19 created havoc in this pandemic season. In this article, six cases of Covid-19 associated Mucormycosis are reported. The timely diagnosis and appropriate management of this deadly invasive disease can help to reduce the mortality and morbidity rate.Some healthy individuals too developed Mucormycosis (phycomycosis, zygomycosis) even when no risk factors were identified. Air conditioning can cause mucosal epithelium dryness, providing an optimal habitat for this organism to grow and multiply, thus leading to Mucormycosis.The global fatality rate for mucormycosis is 46%. Early diagnosis and therapy are crucial because mucormycosis has poor prognosis The diagnosis of mucormycosis depends on pathological findings, clinical features, and imaging, which plays a crucial role in defining the extent of the invasiveness.
Keywords
Corticosteroids; Covid-19; diabetes mellitus (T2DM); immunosuppression; mucormycosis
Statistics
Article View: 633
PDF Download: 509